vs
AdvanSix Inc.（ASIX）与STEPAN CO（SCL）财务数据对比。点击上方公司名可切换其他公司
STEPAN CO的季度营收约是AdvanSix Inc.的1.7倍（$604.5M vs $359.9M），STEPAN CO净利率更高（3.3% vs -0.8%，领先4.0%），AdvanSix Inc.同比增速更快（9.4% vs 1.9%），过去两年STEPAN CO的营收复合增速更高（4.2% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
斯特潘公司是一家美国特种化学品制造商，总部位于伊利诺伊州诺斯布鲁克，1932年由小阿尔弗雷德·C·斯特潘创立，现有约2000名员工，目前由创始人的孙子小F·奎因·斯特潘执掌。该公司是全球最大的阴离子表面活性剂商品生产商，产品用于提升洗涤剂、洗发水、牙膏及化妆品的起泡与清洁能力。
ASIX vs SCL — 直观对比
营收规模更大
SCL
是对方的1.7倍
$359.9M
营收增速更快
ASIX
高出7.5%
1.9%
净利率更高
SCL
高出4.0%
-0.8%
两年增速更快
SCL
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $604.5M |
| 净利润 | $-2.8M | $19.7M |
| 毛利率 | 7.6% | 10.7% |
| 营业利润率 | -0.7% | 4.7% |
| 净利率 | -0.8% | 3.3% |
| 营收同比 | 9.4% | 1.9% |
| 净利润同比 | -892.9% | — |
| 每股收益（稀释后） | $-0.11 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXSCL
| Q1 26 | — | $604.5M | ||
| Q4 25 | $359.9M | $553.9M | ||
| Q3 25 | $374.5M | $590.3M | ||
| Q2 25 | $410.0M | $594.7M | ||
| Q1 25 | $377.8M | $593.3M | ||
| Q4 24 | $329.1M | $525.6M | ||
| Q3 24 | $398.2M | $546.8M | ||
| Q2 24 | $453.5M | $556.4M |
净利润ASIXSCL
| Q1 26 | — | $19.7M | ||
| Q4 25 | $-2.8M | $5.0M | ||
| Q3 25 | $-2.6M | $10.8M | ||
| Q2 25 | $31.4M | $11.3M | ||
| Q1 25 | $23.3M | $19.7M | ||
| Q4 24 | $352.0K | $3.4M | ||
| Q3 24 | $22.3M | $23.6M | ||
| Q2 24 | $38.9M | $9.5M |
毛利率ASIXSCL
| Q1 26 | — | 10.7% | ||
| Q4 25 | 7.6% | 9.3% | ||
| Q3 25 | 6.8% | 12.0% | ||
| Q2 25 | 14.3% | 12.1% | ||
| Q1 25 | 14.2% | 12.7% | ||
| Q4 24 | 3.4% | 10.8% | ||
| Q3 24 | 14.4% | 13.8% | ||
| Q2 24 | 17.9% | 12.5% |
营业利润率ASIXSCL
| Q1 26 | — | 4.7% | ||
| Q4 25 | -0.7% | 1.9% | ||
| Q3 25 | -0.9% | 3.7% | ||
| Q2 25 | 7.7% | 3.0% | ||
| Q1 25 | 7.7% | 4.8% | ||
| Q4 24 | -3.9% | 1.5% | ||
| Q3 24 | 7.5% | 4.4% | ||
| Q2 24 | 11.5% | 3.4% |
净利率ASIXSCL
| Q1 26 | — | 3.3% | ||
| Q4 25 | -0.8% | 0.9% | ||
| Q3 25 | -0.7% | 1.8% | ||
| Q2 25 | 7.7% | 1.9% | ||
| Q1 25 | 6.2% | 3.3% | ||
| Q4 24 | 0.1% | 0.6% | ||
| Q3 24 | 5.6% | 4.3% | ||
| Q2 24 | 8.6% | 1.7% |
每股收益（稀释后）ASIXSCL
| Q1 26 | — | $0.86 | ||
| Q4 25 | $-0.11 | $0.22 | ||
| Q3 25 | $-0.10 | $0.47 | ||
| Q2 25 | $1.15 | $0.50 | ||
| Q1 25 | $0.86 | $0.86 | ||
| Q4 24 | $0.02 | $0.14 | ||
| Q3 24 | $0.82 | $1.03 | ||
| Q2 24 | $1.43 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | — |
| 总债务越低越好 | — | $328.4M |
| 股东权益账面价值 | $815.2M | $1.2B |
| 总资产 | $1.7B | $2.3B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势，按日历期对齐
现金及短期投资ASIXSCL
| Q1 26 | — | — | ||
| Q4 25 | $19.8M | $132.7M | ||
| Q3 25 | $23.7M | $118.5M | ||
| Q2 25 | $18.4M | $88.9M | ||
| Q1 25 | $8.3M | $107.5M | ||
| Q4 24 | $19.6M | $99.7M | ||
| Q3 24 | $17.3M | $147.3M | ||
| Q2 24 | $12.1M | $124.7M |
总债务ASIXSCL
| Q1 26 | — | $328.4M | ||
| Q4 25 | — | $626.7M | ||
| Q3 25 | — | $655.5M | ||
| Q2 25 | — | $658.0M | ||
| Q1 25 | — | $659.3M | ||
| Q4 24 | — | $625.4M | ||
| Q3 24 | — | $688.5M | ||
| Q2 24 | — | $657.1M |
股东权益ASIXSCL
| Q1 26 | — | $1.2B | ||
| Q4 25 | $815.2M | $1.2B | ||
| Q3 25 | $818.2M | $1.2B | ||
| Q2 25 | $823.7M | $1.2B | ||
| Q1 25 | $794.4M | $1.2B | ||
| Q4 24 | $774.6M | $1.2B | ||
| Q3 24 | $766.4M | $1.2B | ||
| Q2 24 | $746.6M | $1.2B |
总资产ASIXSCL
| Q1 26 | — | $2.3B | ||
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.6B | $2.4B | ||
| Q1 25 | $1.6B | $2.4B | ||
| Q4 24 | $1.6B | $2.3B | ||
| Q3 24 | $1.5B | $2.4B | ||
| Q2 24 | $1.5B | $2.3B |
负债/权益比ASIXSCL
| Q1 26 | — | 0.28× | ||
| Q4 25 | — | 0.50× | ||
| Q3 25 | — | 0.53× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.53× | ||
| Q3 24 | — | 0.56× | ||
| Q2 24 | — | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | — |
| 自由现金流经营现金流 - 资本支出 | $36.1M | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 7.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势，按日历期对齐
经营现金流ASIXSCL
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $60.0M | ||
| Q3 25 | $26.6M | $69.8M | ||
| Q2 25 | $21.1M | $11.2M | ||
| Q1 25 | $11.4M | $6.9M | ||
| Q4 24 | $64.2M | $68.3M | ||
| Q3 24 | $57.3M | $22.7M | ||
| Q2 24 | $50.2M | $29.5M |
自由现金流ASIXSCL
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | $25.4M | ||
| Q3 25 | $66.0K | $40.2M | ||
| Q2 25 | $-7.2M | $-14.4M | ||
| Q1 25 | $-22.6M | $-25.8M | ||
| Q4 24 | $29.8M | $32.1M | ||
| Q3 24 | $26.8M | $-4.0M | ||
| Q2 24 | $16.7M | $-208.0K |
自由现金流率ASIXSCL
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | 4.6% | ||
| Q3 25 | 0.0% | 6.8% | ||
| Q2 25 | -1.7% | -2.4% | ||
| Q1 25 | -6.0% | -4.3% | ||
| Q4 24 | 9.1% | 6.1% | ||
| Q3 24 | 6.7% | -0.7% | ||
| Q2 24 | 3.7% | -0.0% |
资本支出强度ASIXSCL
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | 6.3% | ||
| Q3 25 | 7.1% | 5.0% | ||
| Q2 25 | 6.9% | 4.3% | ||
| Q1 25 | 9.0% | 5.5% | ||
| Q4 24 | 10.4% | 6.9% | ||
| Q3 24 | 7.7% | 4.9% | ||
| Q2 24 | 7.4% | 5.3% |
现金转化率ASIXSCL
| Q1 26 | — | — | ||
| Q4 25 | — | 11.99× | ||
| Q3 25 | — | 6.44× | ||
| Q2 25 | 0.67× | 0.99× | ||
| Q1 25 | 0.49× | 0.35× | ||
| Q4 24 | 182.29× | 20.38× | ||
| Q3 24 | 2.57× | 0.96× | ||
| Q2 24 | 1.29× | 3.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
SCL
| Surfactants | $453.7M | 75% |
| Polymers | $130.0M | 22% |
| Specialty Products | $20.8M | 3% |
